CASTORIA, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 9.841
NA - Nord America 5.594
AS - Asia 4.535
SA - Sud America 582
AF - Africa 52
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.620
Nazione #
RU - Federazione Russa 6.023
US - Stati Uniti d'America 5.510
SG - Singapore 1.417
IE - Irlanda 1.022
CN - Cina 989
IT - Italia 910
HK - Hong Kong 584
BR - Brasile 492
UA - Ucraina 474
VN - Vietnam 465
GB - Regno Unito 449
IN - India 323
DE - Germania 313
TR - Turchia 291
KR - Corea 217
FI - Finlandia 184
SE - Svezia 132
FR - Francia 102
JP - Giappone 88
GR - Grecia 78
BE - Belgio 42
CA - Canada 42
AR - Argentina 32
BD - Bangladesh 26
MX - Messico 26
NL - Olanda 26
PK - Pakistan 22
AT - Austria 16
ID - Indonesia 16
IQ - Iraq 16
JO - Giordania 15
EC - Ecuador 13
ES - Italia 12
PL - Polonia 12
VE - Venezuela 11
CO - Colombia 10
MA - Marocco 9
PY - Paraguay 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
IR - Iran 7
KE - Kenya 7
TH - Thailandia 7
AU - Australia 6
BG - Bulgaria 6
DZ - Algeria 6
EG - Egitto 6
PH - Filippine 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
HU - Ungheria 5
NO - Norvegia 5
PE - Perù 5
DO - Repubblica Dominicana 4
HR - Croazia 4
NZ - Nuova Zelanda 4
PA - Panama 4
TN - Tunisia 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
ET - Etiopia 3
IL - Israele 3
LT - Lituania 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
KZ - Kazakistan 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BN - Brunei Darussalam 1
CH - Svizzera 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
Totale 20.613
Città #
Moscow 2.186
Dublin 1.015
San Jose 757
Jacksonville 723
Singapore 715
Chandler 714
Santa Clara 618
Hong Kong 571
Bengaluru 287
Ashburn 240
Ann Arbor 202
Seoul 201
Beijing 175
Hefei 163
Ho Chi Minh City 156
Caserta 147
Princeton 141
Naples 128
Hanoi 124
Boardman 118
Istanbul 104
Medford 100
Roxbury 92
Los Angeles 84
Bremen 82
Woodbridge 75
Wilmington 73
Dallas 68
San Mateo 54
The Dalles 47
São Paulo 43
Cambridge 42
Nanjing 42
Brussels 40
Helsinki 38
New York 37
Rome 37
Da Nang 36
Napoli 33
Houston 32
Munich 30
Aversa 29
Jinan 29
Des Moines 25
Mountain View 23
Turku 23
Rio de Janeiro 22
Orem 21
Pozzuoli 20
Frankfurt am Main 17
London 17
Norwalk 17
Shanghai 17
Kunming 16
Shenyang 16
Milan 15
Tokyo 15
Guangzhou 14
Amman 13
Belo Horizonte 13
Chennai 13
Haiphong 13
Amsterdam 12
Nanchang 12
Afragola 11
Biên Hòa 11
Council Bluffs 11
Düsseldorf 11
Hanover 11
Hải Dương 11
Vienna 11
Atlanta 10
Brooklyn 10
Catanzaro 10
Chicago 10
Memphis 10
Salerno 10
Toronto 10
Seattle 9
Somma Vesuviana 9
Tashkent 9
Tricesimo 9
Zhengzhou 9
Boston 8
Cabo Frio 8
Falkenstein 8
Phoenix 8
Redwood City 8
Tianjin 8
Warsaw 8
Auburn Hills 7
Charlotte 7
Dearborn 7
Dhaka 7
Ercolano 7
Giugliano in Campania 7
Mumbai 7
Nairobi 7
Nuremberg 7
Queens 7
Totale 11.300
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 298
'Role of PI3-K signaling in steroid action’ 214
CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND NERVE GROWTH FACTOR RECEPTOR IN PROSTATE CANCER CELLS: IMPLICATIONS FOR A NEW THERAPEUTIC APPROACH. 199
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 197
Androgen regulation of motility in fibroblasts 196
Effect of new androgen receptor antagonists (SARMs) in the treatment of human prostate cancer. 193
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 187
Calmodulin-stimulated estradiol receptor-tyrosine kinase I 186
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 185
Breast cancer stem cells: The role of sex steroid receptors 185
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 183
Androgen receptor targeted conjugate for bimodal photodynamic therapy of prostate cancer in vitro. 182
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth 181
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 180
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 180
Activation-inactivation of hormone binding sites of the oestradiol-17 beta receptor is a multiregulated process 178
Androgen-induced cell migration: role of androgen receptor/filamin A association. 178
Analysis of the Androgen Receptor/Filamin A Complex in Stromal Cells 177
Patologia Generale 174
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 174
Integrating signals between cAMP and MAPK pathways in breast cancer 172
Crosstalk between EGFR and extranuclear steroid receptors. 171
Sex steroid hormones act as growth factors 170
Protein tyrosine phosphorylation and estradiol action 169
Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/src association 169
Targeting rapid action of sex-steroid receptors in breast and prostate cancers. 168
High-throughput screening identifies kinase inhibitors that increase dual AAV vectors transduction in vitro and in mouse retina. 168
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 167
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor a alpha tyrosine-phosphorylated peptide 166
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 166
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells through AR/Src/PI3-K Complex Assembly. 165
Agri-Food By-Products in Cancer: New Targets and Strategies. 164
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 164
'Steroid-activated PI3-K pathway in target cells'. 163
Advances in Rapid Sex-Steroid Action New Challenges and New Chances in Breast and Prostate Cancers 163
cAMP pathway in differentiating myoblast 162
Action of vanadate on estrogen dependent MCF-7 cells. 162
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 161
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 159
Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications. 159
THE DUAL ROLE OF ANDROGEN RECEPTOR IN MESENCHYMAL CELLS. 158
Rapid signalling pathway activation by androgens in epithelial and stromal cells 158
Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor β. 157
A New Avenue toward Androgen Receptor Pan-antagonists: C2 Sterically Hindered Substitution of Hydroxy-propanamides. 157
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 156
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 155
Differentiation of H9c2 cardiomyoblasts: The role of adenylate cyclase system. 152
EXTRA-NUCLEAR PARTNERS OF ANDROGEN RECEPTOR: AT THE CROSSROADS OF PROLIFERATION, MIGRATION AND NEURITOGENESIS. 151
Src is an initial target of sex steroid hormone action. 150
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 150
ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities 150
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 149
In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor 149
Cell proliferation regulated by estradiol receptor: therapeutic implications. 149
Communication between cells: exosomes as a delivery system in prostate cancer. 149
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 148
The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment. 147
Role of the Androgen Receptor in Gender-Related Cancers. 147
Binary switch between adjacent marks in histone H3 directs productive transcription in estrogen-induced breast cancer cells upon cyclical creation of ROS. 147
Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. 145
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer. 144
A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells 144
The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions. 143
Androgens as the “old age stick” in skeletal muscle (Correction: Androgens as the “old age stick” in skeletal muscle) 141
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 139
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 139
Steroid signaling activation and intracellular localization of sex steroid receptors 138
Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence 137
Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines. 137
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 137
Phosphorylation on tyrosine of oestradiol-17 beta receptor in uterus and interaction of oestradiol-17 beta and glucocorticoid receptors with antiphosphotyrosine antibodies 135
Prostate cancer stem cells: the role of androgen and estrogen receptors. 135
Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers. 135
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models. 134
Non-Steroidal Androgen Receptor Ligands: Versatile Syntheses and Biological Data. 133
Alterazioni del Sistema Endocrino- Sezione E " Fisiopatologia Molecolare degli Organi e dei sistemi"- 133
Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness. 131
Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. 131
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 130
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 130
New insights and emerging therapeutic approaches in prostate cancer. 129
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 128
Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance 127
Filamin A in triple negative breast cancer. 127
The role of androgen receptor/filamin A association in androgen-induced cell migration 126
Searching for a putative mechanism of tumor-promoting function of RIZ2 in cancer models 125
THE ROLE OF THE ANDROGEN RECEPTOR IN SKELETAL MUSCLE SENESCENCE. 124
The role of androgen receptor in stromal cells. 124
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 124
Novel aspects of signalling activation by steroid hormones in target cells. 124
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. 124
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells. 123
Non-genomic action of steroid hormones: More questions than answers 122
Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells 122
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 121
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells 120
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 120
Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens 118
Phosphorylation of uterus estradiol receptor on tyrosine 117
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. 117
Totale 15.347
Categoria #
all - tutte 67.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/20221.028 69 19 18 29 338 32 28 28 28 86 78 275
2022/20232.338 155 71 28 243 242 228 11 174 1.045 24 61 56
2023/2024979 105 39 33 86 282 48 40 55 16 35 96 144
2024/20252.558 14 21 33 171 393 355 374 192 330 278 210 187
2025/202610.798 505 761 466 391 877 5.639 620 545 433 279 152 130
Totale 21.047